FDA Will Make Advisory Committee Review Of Accelerated Approvals An Annual Event

FDA plans to hold a yearly session with its Oncology Drugs Advisory Committee on cancer drugs granted accelerated approval as a means of holding sponsors' feet to the fire with regard to conducting confirmatory trials.